Quantifying the Predictive Power of Social Determinants of Health in Cardiovascular Disease and Type 2 Diabetes Progression Using XGBoost: Retrospective Cohort Study

• by Hielke Muizelaar, Marcel Haas, Maarten van Aken, Rimke Vos, Marco Spruit

• July 9, 2026

Can GDMT Be Safely Stopped After AF Ablation?

Three of 23 patients experienced heart failure deterioration following medication withdrawal, while adverse drug events occurred only among patients who continued therapy.

• by Andrea Surnit

• July 10, 2026

• 3 min

Long-Term Outcomes and Predictors After Percutaneous Balloon Pulmonary Valvuloplasty for Pediatric Isolated Valvular Pulmonary Stenosis: A Systematic Review

• by Mariana M. Pereira, Joana O. Miranda

• July 9, 2026

Sentara Brings 1st Minimally Invasive Treatment for Aortic Regurgitation to Virginia

For decades, open-heart surgery was the only treatment option for people with severe aortic valve disease. Patients too sick to withstand major surgery often faced a steady decline in heart function.

• by

• July 10, 2026

• 4 min